Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model.
Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model.
复制标题
在兔预防模型中用局部加替沙星预防金黄色葡萄球菌眼内炎。
DOI:
10.1089/jop.2006.22.132
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
Solomon,KerryD
中科院分区:
文献类型:
--
作者:
deCastro,LuisEFernandez;Sandoval,HelgaP;Bartholomew,LuannaR;Vroman,DavidT;Solomon,KerryD
Purpose: The aim of this study was to investigate the prophylactic use of 0.3% gatifloxacin drops to prevent endophthalmitis in a rabbit model.Methods: Forty (40) New Zealand white rabbits were randomly placed into group A (20 rabbits) where they received 1 drop of 0.3% gatifloxacin in their right eye every 15 min (0, 15, 30, and 45 min), or group B (20 rabbits) where they received 1 drop of balanced salt solution (BSS) in their right eye every 15 min (0, 15, 30, and 45 min). Following this treatment regimen, the anterior chamber of each rabbit was injected with 0.025 mL of saline containing 5 × 105colonyforming units of a clinical isolate ofStaphylococcus aureus(vancomycin-sensitive). After the inoculum injection, the treatment regimen continued: group A (1 drop of 0.3% gatifloxacin) or group B (1 drop of BSS) immediately postinjection, 6, 12, 18, and 24 h, at which time the animals were examined in a masked fashion, photographed, anesthetized, euthanized, and the aqueous and vitreous humors collected to determine the number of viable bacteria.Results: The median clinical scores for the gatifloxacin group were significantly lower than the control group (P< 0.05). Bacterial recovery ofS. aureuswas significantly higher in the control group in both the aqueous and vitreous humor (P< 0.05).Conclusions: Gatifloxacin-treated eyes demonstrated significantly less inflammation, infection, and culture-positive endophthalmitis (P< 0.05), compared to the control animals. It is important to further investigate the clinical implications from this prophylatic study.
登录
查看更多内容
DOI:
--
发表时间:
1979
期刊:
Cancer treatment reports
影响因子:
--
作者:
J. S. Sierocki;B. Hilaris;S. Hopfan;N. Martini;D. Barton;R. Golbey;R. Wittes
通讯作者:
R. Wittes
DOI:
--
发表时间:
--
期刊:
影响因子:
--
作者:
通讯作者:
--
DOI:
--
发表时间:
1982
期刊:
Cancer treatment reports
影响因子:
--
作者:
Creech,RH;Stanley,K;Vogl,SE;Ettinger,DS;Bonomi,PD;Salazar,O
通讯作者:
Salazar,O
影响因子:
1.6
作者:
Deressa, Temesgen Tadesse;Hassan, Rashid M.
通讯作者:
Hassan, Rashid M.
DOI:
10.1016/s0169-5002(85)80107-0
发表时间:
1985
期刊:
Cancer treatment reports
影响因子:
--
作者:
J. Lopez;J. Mann;R. Grapski;E. Nassif;P. Vannicola;J. Krikorian;H. Finkel
通讯作者:
H. Finkel